pyrroles has been researched along with Hemoptysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahuja, AT; Chan, ATC; Chan, SL; Hui, EP; Kam, MKM; King, AD; Loong, HH; Ma, BBY; Mo, F; Zee, BCY | 1 |
| Deutsch, E; Soria, JC | 1 |
1 trial(s) available for pyrroles and Hemoptysis
| Article | Year |
|---|---|
Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Chemoradiotherapy; Epistaxis; Female; Hematemesis; Hemoptysis; Humans; Indoles; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Sunitinib; Treatment Outcome | 2011 |
1 other study(ies) available for pyrroles and Hemoptysis
| Article | Year |
|---|---|
Hemorrhage caused by antiangiogenic therapy within previously irradiated areas: expected consequence of tumor shrinkage or a warning for antiangiogenic agents combined to radiotherapy?
Topics: Antineoplastic Agents; Carcinoma; Female; Hematemesis; Hemoptysis; Humans; Indoles; Male; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Pyrroles; Sunitinib | 2011 |